Replies to post #113573 on Biotech Values

[DewDiligence]

are you saying NVS reported $170 million while MNTA will report $200-$225 million for Q4?

No, of course not. MNTA’s Lovenox profit share is derived from NVS’ sales to wholesalers/distributors, not from wholesalers/distributors’ sales to end users.